ÂÜÀòÂÒÂ×

Amelie Croset has extensive work experience in various roles and industries. Amelie currently works at Molecular Partners as the Senior Director and Head of Preclinical Pharmacology Platforms. Prior to this, they held positions at the University of Zurich as an LTK M-8E Organizer and Lecturer. Amelie also worked at Ichnos Sciences as the Team Leader and Head of In Vivo Pharmacology and at Glenmark Pharmaceuticals as the Team Leader and Head of In Vivo Pharmacology and Cell Culture and Molecular Biology. Amelie has a strong background in Immuno-Oncology, Respiratory diseases, Inflammation, auto-immune diseases, and Dermatology. Amelie holds a PhD in Cancerology from Institut Curie and a Diploma in Engineering specializing in Biology/Biotechnology from Sup'Biotech, l'école des ingénieurs en biotechnologies. Amelie also completed an internship at Institut Pasteur.

Amelie Croset has a diverse education history spanning from 2002 to 2020. Amelie began their educational journey at Sainte Famille High School, where they obtained a Scientific Baccalaureate. Following this, they attended Assomption Bellevue, where they underwent a preparatory course for the Grandes Ecoles (C.P.G.E) in Biology, Chemistry, Physics, and Earth Science.

In 2006, Amelie enrolled at SupBiotech, an esteemed graduate school specializing in Biology/Biotechnology. Here, they completed their Diploma in Engineering, further honing their skills in this field.

Moving forward, Amelie attended Paris-Sud University (Paris XI) between 2009 and 2013. During this period, they pursued a PhD in Cancerology under the École Doctorale de Cancérologie of Gustave Roussy. This doctoral program allowed their to specialize in the study of cancer.

Progressing in their career, Amelie undertook additional training in animal experimentation and laboratory animal science. In 2010, they acquired a Diploma of Animal Testing Level I from Faculté de Sciences Humaines et Sociales - Sorbonne (Université Paris Descartes), focusing on research related to animals. In 2013, they participated in the LTK Modul1E - Introductory Course in Laboratory Animal Science - Rodents at the University of Zurich. Following this, in 2016, they completed the LTK Modul2E – Education for persons responsible for directing animal experiments (study directors) at the same university.

In 2020, they engaged in a curriculum for Biosafety level 2 - BSO at the University of Bern, enhancing their expertise in Health, Safety and Environment (HSE).

Amelie Croset's extensive education history reflects their dedication to continuously expanding their knowledge and skills in various scientific disciplines, predominantly in cancerology, biotechnology, animal experimentation, and laboratory animal science.